Rolf Magnus Björsne
Chief Executive Officer chez AstraZeneca BioVentureHub AB
Profil
Rolf Magnus Björsne is currently the Chief Executive Officer at AstraZeneca BioVentureHub AB, Chairman at Termino C 2915 AB, and Director at SwedenBIO Service AB.
He previously worked as a Director at Beactica Therapeutics AB from 2014 to 2018 and as an Independent Director at Isofol Medical AB from 2018 to 2023.
Björsne holds a doctorate from the University of Stockholm and an MBA from Henley Management College.
Postes actifs de Rolf Magnus Björsne
| Sociétés | Poste | Début |
|---|---|---|
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Director/Board Member | - |
| Termino C 2915 AB | Chairman | - |
| AstraZeneca BioVentureHub AB | Chief Executive Officer | - |
Anciens postes connus de Rolf Magnus Björsne
| Sociétés | Poste | Fin |
|---|---|---|
| ISOFOL MEDICAL AB | Director/Board Member | 01/02/2023 |
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Director/Board Member | 01/01/2018 |
Formation de Rolf Magnus Björsne
| University of Stockholm | Doctorate Degree |
| Henley Management College | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ISOFOL MEDICAL AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Termino C 2915 AB | |
| AstraZeneca BioVentureHub AB |
